Registration - Amendment

NOVO NORDISK INC. for NOVO NORDISK INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Veterans VET

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Health Issues HCR

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Medicare/Medicaid MMM

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Pharmacy PHA

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Defense DEF

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Taxation/Internal Revenue Code TAX

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Copyright/Patent/Trademark CPT

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

LobbyistCovered position, as disclosed
BRIAN BRANTON New —
TRICIA BROOKS New —
AMANDA MAKKI New —
SARAH ELIZABETH NORDSTROM New —
LAUREN ELIZABETH SEMENIUK New —
AMY WOTRING New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
NOVO NORDISK FONDEN (ULTIMATE PARENT COMPANY). Denmark Denmark 100.0% —
NOVO A/S (OWNS 26.5% OF NN A/S). Denmark Denmark 26.0% —
REGISTRANT IS A WHOLLY-OWNED SUBSIDIARY OF NOVO NORDISK US WHICH IS WHOLLY-OWNED BY NOVO NORDISK A/S. Denmark Denmark 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.